Filgrastim

Filgrastim is indicated to those:

Cancer patients receiving myelosuppressive chemotherapy
Patients with Acute Myeloid Leukemia receiving induction or consolidation chemotherapy
Cancer patients receiving bone marrow transplant
Patients with severe neutropenia
Peripheral blood progenitor cell collection and therapy

There are no products to list in this category.